Alumis (ALMS) Non Operating Income (2023 - 2025)
Alumis (ALMS) reported Non Operating Income of -$33000.0 for Q4 2025, down 725.0% year-over-year from $5280.0 in Q4 2024, and down 100.73% quarter-over-quarter from $4.5 million in Q3 2025.
Alumis (ALMS) Non Operating Income (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Non Operating Income data on file, last reported at -$33000.0 in Q4 2025.
- Non Operating Income for Q4 2025 came in at -$33000.0, down 725.0% year-over-year; the trailing twelve-month figure through Dec 2025 was $195.8 million (up 7276.11% YoY), and the FY2025 annual result was -$169000.0, down 81.72% from the prior year.
- Non Operating Income declined to -$33000.0 in Q4 2025 per ALMS's latest filing, from $4.5 million in the prior quarter.
- Over five years, Non Operating Income peaked at $191.3 million in Q2 2025 and troughed at -$2.3 million in Q1 2024.
- A 3-year average of $18.0 million and a median of -$18000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Income plunged 3245.45% in 2024, then surged 52083.42% in 2025.
- A 3-year view of Non Operating Income shows it stood at -$27000.0 in 2023, then surged by 85.19% to -$4000.0 in 2024, then tumbled by 725.0% to -$33000.0 in 2025.
- Business Quant data shows ALMS's Non Operating Income at -$33000.0 in Q4 2025, $4.5 million in Q3 2025, and $191.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Alumis | 1.99 Bn | 1.90 Bn | - | -33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -33,000.00 |
| Sep 30, 2025 | 4.54 Mn |
| Jun 30, 2025 | 191.30 Mn |
| Mar 31, 2025 | -44,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | -368,000.00 |
| Mar 31, 2024 | -2.26 Mn |
| Dec 31, 2023 | -27,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -11,000.00 |